The present invention relates to an auto injector (1) comprising a prefilled liquid medicament container, a hollow auto injector body (2) housing the medicament container. The auto injector body (2) has an elongated part, a first end side (21) and a second end side (22) and at least one through hole (3) arranged between the end sides (21, 22). The through holes (3) allow for flow of gas through the auto injector body (2) when the auto injector body (2) houses the medicament container. The invention further relates to a method comprising inserting the auto injector (1) into the package via an opening in a non-inert environment, and, in a non-inert environment and under atmospheric pressure: replacing the air in the package with inert atmosphere by one or several cycles of removing air and inserting inert gas through the opening, wherein the air and inert gas in part flows through the at least one through hole (3) of the auto injector (1). The method further comprises sealing the opening under vacuum.

A method includes moving an actuation lock of a medical injector from a first position to a second position. The actuation lock has an extended portion disposed between a shoulder of a housing and the base when the actuation lock is in the first position. The extended portion is spaced apart from the base when the actuation lock is in the second position. A distal end portion of a base, which is movably coupled to an end portion of the housing, is placed into contact with a body. The base is actuated after the placing to release an energy from an energy storage member within the housing to produce a force to move a needle from a first needle position to a second needle position. At least a portion of the needle extends through the base when the needle is in the second needle position.

Described here are systems and methods for accessing Schlemm's canal, for delivering a fluid composition therein, and for tearing the trabecular meshwork. The fluid composition may be a viscoelastic fluid that is delivered into the canal to facilitate drainage of aqueous humor by disrupting the canal and surrounding trabeculocanalicular tissues. The systems described here may be configured to cut or tear the trabecular meshwork with the body of an elongate member located within Schlemm's canal.

A packaging for medical devices, including a tub provided with a peripheral wall delimiting an upper opening, a sealing cover sealable on the upper opening of the tub, and a sealing film adapted to be positioned on the upper face of the sealing cover. The sealing film, including a protective foil, an adhesive layer extending over the protective foil, and a peelable sheet having a first portion extending over the adhesive layer opposite to a first portion of the protective foil. The first portions of the protective foil and peelable sheet are arranged in a retracted position uncovering the sealing cover. A second portion of the protective foil, distinct from the first portion, is bonded to the sealing cover and/or to the tub by the adhesive layer, and a second portion of the peelable sheet, separated from said second portion of the protective foil, is arranged so as to be pullable by a user to progressively separate the first portion of the peelable sheet from the first portion of the protective foil to an extended position wherein the protective foil adheres to the sealing cover.

The present invention relates to a pre-filled syringe containing a VEGF antagonist and comprising a plastic barrel which is silicone-free, kits comprising this syringe and the use of the syringe for the administration of a VEGF antagonist in the treatment of ocular diseases.

A prepackaged needleless intravenous line assembly is provided as well as a method of delivering intravenous medication and/or fluid to a patient while maintaining sterility of needleless access ports. The pre-packaged needleless intravenous line assembly is a sterile intravenous line with at least one sterile access port, each access port having a disinfection cap installed thereon, sealed within a pouch with at least one strip of multiple sealed disinfection caps. An intravenous tubing kit, having sterile intravenous tubing with capped sterile access ports as well as sealed replacement disinfection caps, is removed from the package and attached to a patient's intravenous catheter. A disinfection cap is removed from the sterile access port. Medication and/or fluid is administered into the access port. A replacement disinfection cap is installed onto the access port.

A needle assembly is disclosed, for use with an injection device. The needle assembly comprises a needle hub (20) having a needle (22) and a needle shield (40) arranged for relative axial movement with respect to the needle hub, between a retracted position in which the tip of the needle projects beyond a forward end of the shield and an extended position in which the tip of the needle does not project beyond the forward end of the shield. The needle shield (40) is axially biased towards the extended position. The needle shield (40) is further arranged to be torsionally biased for relative rotational movement with respect to the needle hub (20).

A syringe set, a syringe and a set include a first syringe having a first connection port and a drug container having a second connection port. The first connection port includes an injection needle attachment structure to which an injection needle is attachable, and a blocking member that is disposed in the injection needle attachment structure and blocks attachment of the injection needle. When the second connection port is connected to the first connection port, the blocking member is connected to the second connection port side, and when the second connection port is detached, the blocking member is detached from the first connection port so as to allow the injection needle to be attached to the first connection port.

A cartridge for use with a beneficial agent delivery device having a fillable reservoir. The cartridge includes a reconstitution, unit dose package having first and second compartments, and a fitment. The first compartment contains at least a first constituent of the beneficial agent. The second compartment contains at least a second constituent of the beneficial agent. The fitment is disposed on the package for interfacing the package to the fillable reservoir.

A prefilled syringe includes a syringe body filled with a medical fluid, which has a nozzle at a front side, the nozzle being closed with a cap, and which is closed at a rear side with a displaceable plunger; and a plunger rod that can be inserted into the syringe body via the rear side. The plunger rod has a connecting portion at a front side, via whi9ch the plunger rod can be connected to the plunger. At least three annular elements, which extend at least in some sections about a longitudinal axis of the rod, are arranged on a rear side of the connecting portion on the plunger rod in such a manner that they are located in the syringe body when the plunger rod is fully connected to the plunger. The three annular elements support a coaxial connection of the rod to the plunger positioned in the syringe.